Evidence map›Paper›PMID 34805986›Full record

ArticleCrohn's & colitis 3602021

A Patient-Prioritized Agenda for Information Needs During the COVID-19 Pandemic: A Qualitative Study of Patients With Inflammatory Bowel Disease.

Millie D Long, Mary E Grewe, Emily Cerciello, Laura Weisbein, Kyra Catabay, Michael D Kappelman

Open access · goldAbstract read
In one paragraph

Article in Crohn's & colitis 360, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Millie D LongUniversity of North Carolina, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina, USA.ORCID https://orcid.org/0000-0001-5983-2758
Mary E GreweUniversity of North Carolina, NC TraCS Institute-Community and Stakeholder Engagement Program (CaSE), Chapel Hill, North Carolina, USA.
Emily CercielloCrohn's and Colitis Foundation, New York, New York, USA.
Laura WeisbeinCenter for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA.
Kyra CatabayCenter for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA.
Michael D KappelmanCenter for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, North Carolina, USA.
University of North Carolina at Chapel Hill · USCrohn's and Colitis Foundation · US

Funding

Re-Entry Supplement: Investigation of Oral Microbial Enzymes for the Detection and Treatment of Periodontal DiseaseUL1TR002489 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, SHAHEEN, NICHOLAS J · 2018 to 2022
$48.6M
Epidemiologic Case-control Study of Barrett's EsophagusK23DK059311 · NIDDK · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI SHAHEEN, NICHOLAS J · 2001 to 2005
$626k
NCATS NIH HHS UL1 TR002489NIDDK NIH HHS K23 DK059311
6 · The paper itself

Abstract

backgroundPatients with inflammatory bowel disease (IBD) may be at risk for complications due to the COVID-19 pandemic. We performed a qualitative study to better understand IBD patient experiences and concerns when navigating the COVID-19 pandemic, with the goal of prioritizing patients' information needs.

methodsWe conducted a series of semistructured virtual focus groups at 6 months, then member checking focus groups 1 year into the COVID-19 pandemic. We included questions on patients' experiences navigating the pandemic with IBD, differences in their experience as compared to peers, their concerns and fears, as well as preferred information sources. Transcribed focus groups were coded and content analyzed to summarize key areas of interest and identify themes. We focused on 4 areas in our content analysis process: fears, challenges, information preferences, and research questions.

resultsA total of 26 IBD patient participants were included in the initial focus groups. Findings highlighted the many challenges faced by patients during the COVID-19 pandemic, ranging from access (bathrooms, medications, healthcare) to significant fears and concerns surrounding medications used for IBD worsening risks of COVID-19. Research questions of importance to patients centered on understanding risks for COVID-19 complications, particularly pertaining to medication utilization, with a shift over time toward understanding COVID-19 vaccination. In our member checking focus groups (

conclusionsInformation needs for patients during the COVID-19 pandemic centered upon understanding disease-specific risks. Identified challenges and fears will inform future research agendas and communication with patients.

Indexed as

COVID-19Crohn’s diseasefocus groupsinflammatory bowel diseaseulcerative colitis

Identifiers

PMID34805986
PMCPMC8600949
OpenAlexW3201569857

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.